research

19 March, 2025

Ignacio Ochoa Garrido: “Don't try to cure diseases on the first day; science is an endurance race.”

In this interview, IIS Aragón researcher talks about his work leading the Tissue Microenvironment Lab (TME Lab) (GIIS018) group and his lines of research.
14 March, 2025

Aragonese researchers discover a new marker for detecting cardiovascular risk in patients with sleep apnea.

The study is being promoted by the "Precision Medicine in Respiratory Diseases" (GIIS041) group at the IIS Aragón. The research focuses on how obstructive sleep apnea affects the heart and blood vessels.
25 February, 2025

Researchers from IIS Aragón and I3A create a microfluidic device to better understand the communication between a brain tumor and the immune system

The TME Lab research group has developed the new device that allows studying the interaction between tumor and immune cells. The scientific journal Nano-Micro Small has published the research.
24 February, 2025

NanoLyme: nanotechnology and artificial intelligence for a new diagnosis of Lyme disease

The IIS Aragón is collaborating with the University of Zaragoza, the CNRS and the Lannemezan University Hospital on this project, which has received funding of over 1 million euros. NanoLyme seeks to directly detect the bacteria responsible for Lyme disease.
21 February, 2025

Neurodegenerative diseases: the virus-brain connection

Researchers Isidoro Martínez González and Salvador Resino García, both from the Carlos III Health Institute (ISCIII), have published an article where scientific evidence links the presence of certain viruses with diseases such as Alzheimer's, Parkinson's and ALS.
19 February, 2025

Luis Moreno Aznar: “It is advisable to avoid trends and follow a consistent line of work”

In this interview, the IIS Aragón researcher talks about his work leading the Growth, Exercise, Nutrition and Development (GENUD) group (GIIS066) and his most notable project.
5 February, 2025

Dolores Isla Casado: “Getting involved in health research is always worthwhile”

In this interview, the IIS Aragón researcher talks about her work leading the 'Medical Oncology Hospital Clínico Lozano Blesa' group (GIIS025) and the profiles that make it up.